The meta-analysis further broke down how common nausea is for the five FDA-approved GLP-1 drug types, and another study looked at tirzepatides rate: Dulaglutide: 5-29% Exenatide: 5-59% Liraglutide: 10-48% Lixisenatide: 16-40% Semaglutide: 8-58% Tirzepatide: 20.43% Youll notice that these percentages vary quite a bit
When you can see your progress charted over weeks, the temporary discomfort of side effects feels more manageable because you can see the trend improving
The medication dramatically reduces appetite
Ozempic and Mounjaro, as well as their weight loss versions, Wegovy and Zepbound, all belong to a class of medications known as glucagon-like peptide 1 (GLP-1) receptor agonists
Apr 14, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Safety, Type 2 Diabetes, Type 2 Diabetes 1,531 views A proper baseline assessment for GLP-1 therapy has become a critical yet sometimes overlooked step in modern diabetes care
Case studies indicate GLP-1RAs could cause hair thinning or shedding potentially due to rapid weight loss and nutritional deficiencies or because of direct effects on hair follicles [23]